2020 Q2 Form 10-Q Financial Statement

#000114036120018304 Filed on August 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $62.47M $63.57M
YoY Change -1.73% 4.01%
Cost Of Revenue $26.25M $29.75M
YoY Change -11.78% -1.42%
Gross Profit $36.23M $33.82M
YoY Change 7.11% 9.3%
Gross Profit Margin 57.99% 53.2%
Selling, General & Admin $35.16M $35.91M
YoY Change -2.09% 4.18%
% of Gross Profit 97.07% 106.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.900M $1.900M
YoY Change 0.0% -9.52%
% of Gross Profit 5.24% 5.62%
Operating Expenses $35.16M $35.91M
YoY Change -2.09% 4.18%
Operating Profit $1.160M -$2.093M
YoY Change -155.42% -40.59%
Interest Expense $327.0K $829.0K
YoY Change -60.55% 53.8%
% of Operating Profit 28.19%
Other Income/Expense, Net
YoY Change
Pretax Income $833.0K -$2.920M
YoY Change -128.53% -27.97%
Income Tax $100.0K $144.0K
% Of Pretax Income 12.0%
Net Earnings $783.0K -$3.064M
YoY Change -125.55% -25.34%
Net Earnings / Revenue 1.25% -4.82%
Basic Earnings Per Share $0.02 -$0.12
Diluted Earnings Per Share $0.02 -$0.12
COMMON SHARES
Basic Shares Outstanding 24.74M 24.56M
Diluted Shares Outstanding 24.74M 24.56M

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.30M $6.500M
YoY Change 258.46% 109.68%
Cash & Equivalents $23.34M $6.489M
Short-Term Investments
Other Short-Term Assets $6.600M $9.500M
YoY Change -30.53% -14.41%
Inventory $3.107M $2.086M
Prepaid Expenses
Receivables $27.91M $22.08M
Other Receivables $0.00 $0.00
Total Short-Term Assets $61.01M $40.18M
YoY Change 51.84% 9.48%
LONG-TERM ASSETS
Property, Plant & Equipment $49.17M $47.48M
YoY Change 3.56% -11.25%
Goodwill $14.54M $14.54M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.003M $1.091M
YoY Change -8.07% -16.08%
Total Long-Term Assets $133.9M $114.7M
YoY Change 16.71% 45.03%
TOTAL ASSETS
Total Short-Term Assets $61.01M $40.18M
Total Long-Term Assets $133.9M $114.7M
Total Assets $194.9M $154.9M
YoY Change 25.83% 33.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.06M $18.41M
YoY Change -23.64% 18.02%
Accrued Expenses $12.16M $9.123M
YoY Change 33.31% -25.22%
Deferred Revenue $17.57M $19.72M
YoY Change -10.87%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.000M $4.579M
YoY Change -56.32%
Total Short-Term Liabilities $68.57M $62.76M
YoY Change 9.26% 31.57%
LONG-TERM LIABILITIES
Long-Term Debt $16.12M $21.44M
YoY Change -24.79% -11.79%
Other Long-Term Liabilities $1.014M $89.00K
YoY Change 1039.33% -98.95%
Total Long-Term Liabilities $17.14M $21.52M
YoY Change -20.39% -34.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $68.57M $62.76M
Total Long-Term Liabilities $17.14M $21.52M
Total Liabilities $140.9M $123.0M
YoY Change 14.49% 52.83%
SHAREHOLDERS EQUITY
Retained Earnings -$43.03M -$52.60M
YoY Change -18.21%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $82.86M $82.86M
YoY Change 0.0%
Treasury Stock Shares $5.911M $5.911M
Shareholders Equity $42.06M $31.87M
YoY Change
Total Liabilities & Shareholders Equity $194.9M $154.9M
YoY Change 25.83% 33.76%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $783.0K -$3.064M
YoY Change -125.55% -25.34%
Depreciation, Depletion And Amortization $1.900M $1.900M
YoY Change 0.0% -9.52%
Cash From Operating Activities $18.40M $100.0K
YoY Change 18300.0% -104.35%
INVESTING ACTIVITIES
Capital Expenditures -$1.800M -$600.0K
YoY Change 200.0% -53.85%
Acquisitions
YoY Change
Other Investing Activities $100.0K $0.00
YoY Change
Cash From Investing Activities -$1.700M -$600.0K
YoY Change 183.33% -53.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -500.0K 1.200M
YoY Change -141.67% -33.33%
NET CHANGE
Cash From Operating Activities 18.40M 100.0K
Cash From Investing Activities -1.700M -600.0K
Cash From Financing Activities -500.0K 1.200M
Net Change In Cash 16.20M 700.0K
YoY Change 2214.29% -138.89%
FREE CASH FLOW
Cash From Operating Activities $18.40M $100.0K
Capital Expenditures -$1.800M -$600.0K
Free Cash Flow $20.20M $700.0K
YoY Change 2785.71% -170.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14584000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
14058000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20652000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27906000
CY2020Q2 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
15787000
CY2019Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
15337000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12162000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7869000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
172408000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
175183000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3456000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4019000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30145000
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30589000
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
7435000
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-2251000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
2932000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
2260000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
20661000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
18107000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
194000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
90000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5979960
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
118348
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
61138
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5897416
CY2020Q2 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
84723000
CY2019Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
94941000
CY2019Q4 us-gaap Assets
Assets
194763000
CY2020Q2 us-gaap Assets
Assets
194901000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
50477000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
61006000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23342000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23644000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-12676000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-34960000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45946000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38644000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25968000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10986000
CY2020Q2 us-gaap Cash
Cash
7800000
CY2019Q4 us-gaap Cash
Cash
4600000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32386438
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31142251
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
141377000
CY2020Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
141377000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31142251
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32386438
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
828000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1530000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2910000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8223000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
23411000
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
17573000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
22200000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
26245000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
59728000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
56482000
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
29749000
us-gaap Costs And Expenses
CostsAndExpenses
133791000
us-gaap Costs And Expenses
CostsAndExpenses
132696000
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
65662000
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
61310000
CY2020Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
6600000
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
153000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
153000
CY2020Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
712000
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
805000
CY2019Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
4015000
CY2020Q2 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
3850000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3763000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3989000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-177000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.023
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.060
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.115
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.049
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
96000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1000
CY2020Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
97000
CY2019Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
96000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1000
us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
0
us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
0
CY2019Q4 us-gaap Goodwill Gross
GoodwillGross
117176000
CY2020Q2 us-gaap Goodwill Gross
GoodwillGross
117176000
CY2019Q2 us-gaap Goodwill Gross
GoodwillGross
117176000
CY2018Q4 us-gaap Goodwill Gross
GoodwillGross
117176000
CY2019Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
102640000
CY2020Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
102640000
CY2019Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
102640000
CY2018Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
102640000
CY2020Q2 us-gaap Goodwill
Goodwill
14536000
CY2019Q4 us-gaap Goodwill
Goodwill
14536000
CY2019Q2 us-gaap Goodwill
Goodwill
14536000
CY2018Q4 us-gaap Goodwill
Goodwill
14536000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Interest Expense
InterestExpense
682000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
833000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-867000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2920000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8337000
us-gaap Income Tax Expense Benefit Continuing Operations Discontinued Operations Extraordinary Items
IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems
424000
us-gaap Income Tax Expense Benefit Continuing Operations Discontinued Operations Extraordinary Items
IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems
0
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
144000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
194000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50000
us-gaap Income Taxes Paid
IncomeTaxesPaid
14000
us-gaap Income Taxes Paid
IncomeTaxesPaid
99000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
649000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
122000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2829000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5838000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4271000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-615000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20322000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13818000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-470000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4293000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-93000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
635000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1499000
us-gaap Interest Expense
InterestExpense
1386000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-34000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1060000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-346000
CY2019Q2 us-gaap Interest Expense
InterestExpense
829000
CY2020Q2 us-gaap Interest Expense
InterestExpense
327000
us-gaap Interest Paid Net
InterestPaidNet
589000
us-gaap Interest Paid Net
InterestPaidNet
1073000
CY2019Q4 us-gaap Inventory Net
InventoryNet
1608000
CY2020Q2 us-gaap Inventory Net
InventoryNet
3107000
us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
us-gaap Investment Income Interest
InvestmentIncomeInterest
7000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
11926000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
24846000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
17196000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7691000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
10689000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
84216000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
9116000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
13553000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
14045000
CY2019Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
4000000
CY2020Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
4000000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
1030000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
614000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
194901000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
194763000
CY2020Q2 us-gaap Liabilities
Liabilities
140857000
CY2019Q4 us-gaap Liabilities
Liabilities
139633000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
68571000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
57205000
CY2020Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2000000
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2000000
CY2020Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1500000
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1000000
CY2019Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
34028000
CY2020Q2 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
18121000
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
18833000
CY2019Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
32028000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6468000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
783000
CY2020Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
16121000
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2000000
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2000000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
32028000
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
16121000
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2000000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2000000
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2000000
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
11833000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10782000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-3064000
us-gaap Net Income Loss
NetIncomeLoss
-967000
us-gaap Net Income Loss
NetIncomeLoss
-8531000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-1750000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-5467000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1212000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2975000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1577000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3064000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
372000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8531000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22966000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16169000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2020Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
14
us-gaap Operating Lease Payments
OperatingLeasePayments
7603000
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
3802000
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
3821000
us-gaap Operating Lease Payments
OperatingLeasePayments
7643000
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1194
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1443
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
59370000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
51148000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
46018000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9142000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8222000
us-gaap Operating Lease Cost
OperatingLeaseCost
7300000
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
3600000
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
3700000
us-gaap Operating Lease Cost
OperatingLeaseCost
7400000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
49065000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
53397000
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y4M20D
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y7M17D
CY2019Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-154000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1160000
us-gaap Operating Income Loss
OperatingIncomeLoss
-185000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2093000
us-gaap Operating Income Loss
OperatingIncomeLoss
-6958000
CY2019Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-154000
linc Credit Payment Of Financing Costs
CreditPaymentOfFinancingCosts
-3000
CY2020Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-140000
CY2020Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-140000
CY2020Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
0
CY2019Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
0
CY2020Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-95000
CY2019Q2 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
0
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
0
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-843000
CY2020Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-748000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1003000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1003000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
199000
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
93000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
214000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1014000
CY2019Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
0
CY2020Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
0
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-308000
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-280000
CY2019Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-154000
CY2020Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-140000
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
18000
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
172000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3072000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1212000
CY2019Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0
CY2020Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
305000
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
610000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4190000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3748000
CY2020Q2 us-gaap Prepaid Taxes
PrepaidTaxes
277000
CY2019Q4 us-gaap Prepaid Taxes
PrepaidTaxes
383000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3750000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
11000000
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
0
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
97000
us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
-334000
us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
-893000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49345000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49172000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
12618000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
8923000
CY2020Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8469000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
48634000
CY2019Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
657000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8518000
CY2020Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
15000000
linc Credit Payment Of Financing Costs
CreditPaymentOfFinancingCosts
98000
linc Increase Decrease In Cares Act Student Funds Liability
IncreaseDecreaseInCaresActStudentFundsLiability
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
27000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
26600000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
0
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
15000000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2626000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42058000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43025000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
62470000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
63569000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132511000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
126833000
CY2020Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
10.56
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y3M29D
CY2020Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
10.56
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P1Y3M29D
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P1Y3M29D
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y9M29D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y3M29D
linc Increase Decrease In Cares Act Student Funds Liability
IncreaseDecreaseInCaresActStudentFundsLiability
2626000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35162000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
74062000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35913000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
76310000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation
ShareBasedCompensation
242000
us-gaap Share Based Compensation
ShareBasedCompensation
616000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
116000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
116000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
116000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.56
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.56
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
10.56
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
116000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
10.56
CY2020Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
116000
CY2020Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
116999
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
18000
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
172000
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
325000
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
291000
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
191000
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
52000
CY2019Q4 linc Cares Act Institutional Funds Liability
CaresActInstitutionalFundsLiability
0
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
40909000
CY2020Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
31868000
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5910541
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
5910541
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
34587000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
42062000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
43148000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
39866000
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
82860000
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
82860000
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2019Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div><font style="font-weight: bold; font-style: italic; color: #000000;">Use of Estimates in the Preparation of Financial Statements</font><font style="color: #000000;"> &#8211; The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period.&#160; On an ongoing basis, the Company evaluates the estimates and assumptions, including those used to determine the incremental borrowing rate to calculate lease liabilities and right-of-use </font>(&#8220;ROU&#8221;) <font style="color: #000000;">assets, lease term to calculate lease cost, revenue recognition, bad debts, impairments, useful lives of fixed assets, income taxes, benefit plans and certain accruals.&#160; Actual results could differ from those estimates.</font></div></div>
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
500000
us-gaap Variable Lease Cost
VariableLeaseCost
500000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24555435
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24669838
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24741331
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24544879
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24555435
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24669838
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24544879
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24741331
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
LINCOLN EDUCATIONAL SERVICES CORP
dei Entity Central Index Key
EntityCentralIndexKey
0001286613
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26400782
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Shell Company
EntityShellCompany
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
true
CY2019Q4 linc Cares Act Student Funds Liability
CaresActStudentFundsLiability
0
CY2020Q2 linc Cares Act Student Funds Liability
CaresActStudentFundsLiability
2626000
CY2020Q2 linc Cares Act Institutional Funds Liability
CaresActInstitutionalFundsLiability
11837000
linc Increase Decrease In Cares Act Institutional Funds Liability
IncreaseDecreaseInCaresActInstitutionalFundsLiability
11837000
linc Increase Decrease In Cares Act Institutional Funds Liability
IncreaseDecreaseInCaresActInstitutionalFundsLiability
0
CY2020Q2 linc Line Of Credit Facility Additional Borrowing Capacity Under Cares Act
LineOfCreditFacilityAdditionalBorrowingCapacityUnderCARESAct
21000000
linc Number Of Campuses Treated As Destination Schools
NumberOfCampusesTreatedAsDestinationSchools
5
linc Number Of Schools
NumberOfSchools
22
CY2020Q2 linc Cash Received Under The Cares Act
CashReceivedUnderTheCARESAct
14500000
linc Increase Decrease In Prepaid Income Taxes And Income Taxes Receivable
IncreaseDecreaseInPrepaidIncomeTaxesAndIncomeTaxesReceivable
211000
linc Allocation To Preferred Stockholders
AllocationToPreferredStockholders
0
CY2020Q2 linc Allocation To Preferred Stockholders
AllocationToPreferredStockholders
83000
linc Allocation To Preferred Stockholders
AllocationToPreferredStockholders
0
CY2019Q2 linc Allocation To Preferred Stockholders
AllocationToPreferredStockholders
0
CY2020Q2 linc Allocation To Restricted Stockholders
AllocationToRestrictedStockholders
23000
CY2019Q2 linc Allocation To Restricted Stockholders
AllocationToRestrictedStockholders
0
linc Allocation To Restricted Stockholders
AllocationToRestrictedStockholders
0
linc Allocation To Restricted Stockholders
AllocationToRestrictedStockholders
0
CY2019Q2 linc Percentage Of Total Revenue
PercentageOfTotalRevenue
1.000
linc Percentage Of Total Revenue
PercentageOfTotalRevenue
1.000
linc Percentage Of Total Revenue
PercentageOfTotalRevenue
1.000
CY2020Q2 linc Percentage Of Total Revenue
PercentageOfTotalRevenue
1.000
linc Number Of Installments To Receive Cares Act Fund
NumberOfInstallmentsToReceiveCARESActFund
2
CY2020Q2 linc Amount Expected To Be Received Under Cares Act
AmountExpectedToBeReceivedUnderCARESAct
27400000
CY2020Q2 linc Emergency Grants Received In Second Installment Under Cares Act
EmergencyGrantsReceivedInSecondInstallmentUnderCARESAct
13200000
CY2020Q2 linc Reimbursed Amount Of Permitted Expenses
ReimbursedAmountOfPermittedExpenses
1300000
CY2020Q2 linc Emergency Grants Received In First Installment Under Cares Act
EmergencyGrantsReceivedInFirstInstallmentUnderCARESAct
13700000
CY2020Q2 linc Emergency Grants Distributed To Students Under Cares Act
EmergencyGrantsDistributedToStudentsUnderCARESAct
11100000
linc Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
3
linc Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodTotalIntrinsicValue
0
linc Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodTotalIntrinsicValue
0
linc Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodTotalIntrinsicValue
0
linc Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePricePerShare
0
linc Increase Decrease In Prepaid Income Taxes And Income Taxes Receivable
IncreaseDecreaseInPrepaidIncomeTaxesAndIncomeTaxesReceivable
-106000
CY2020Q2 linc Operating Lease Right Of Use Asset Change In Measurement
OperatingLeaseRightOfUseAssetChangeInMeasurement
8700000
CY2020Q2 linc Lessee Deferred Rental Payment
LesseeDeferredRentalPayment
1200000
linc Lessee Recognition Of Negative Lease Expense
LesseeRecognitionOfNegativeLeaseExpense
500000

Files In Submission

Name View Source Status
0001140361-20-018304-index-headers.html Edgar Link pending
0001140361-20-018304-index.html Edgar Link pending
0001140361-20-018304.txt Edgar Link pending
0001140361-20-018304-xbrl.zip Edgar Link pending
brhc10014337_10q.htm Edgar Link pending
brhc10014337_ex31-1.htm Edgar Link pending
brhc10014337_ex31-2.htm Edgar Link pending
brhc10014337_ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
linc-20200630.xml Edgar Link completed
linc-20200630.xsd Edgar Link pending
linc-20200630_cal.xml Edgar Link unprocessable
linc-20200630_def.xml Edgar Link unprocessable
linc-20200630_lab.xml Edgar Link unprocessable
linc-20200630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending